October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...
Stents Drug Eluting
This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.
![People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019](/sites/default/files/styles/content_feed_large/public/field/image/EXCEL_Data_Presentation_TCT19_Staff_DF.jpg?itok=nRZgfSBn)
September 30, 2019 – The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug ...
September 30, 2019 — A biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual ...
September 25, 2019 — Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting ...
September 5, 2019 — Biotronik's ultrathin Orsiro stent demonstrated superiority over Xience with respect to target ...
![FDA Panel Recommends Continued Use of Paclitaxel-coated Peripheral Devices](/sites/default/files/styles/content_feed_large/public/field/image/PhilipsStellarexDCBPaclitaxel.jpg?itok=T-xZ_hP3)
August 28, 2019 — The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the ...
August 21, 2019 — Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the ...
April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S ...
![](/sites/default/files/styles/content_feed_large/public/field/image/Biotronik_Orsiro_Stent_strut_thickness_comparison.jpg?itok=ToDg4waV)
February 22, 2019 — The U.S. Food and Drug Administration (FDA) has approved the Biotronik Orsiro drug-eluting stent ...
Clinical study data makes the world go around in cardiology and is the basis of setting guidelines in evidence-based ...
![The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.](/sites/default/files/styles/content_feed_large/public/field/image/Eluvia_PAD_stent.jpg?itok=nXJ-ccjx)
In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...
![The Medtronic Resolute Integrity drug-eluting stent is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data. Stent advances and new stent technologies.](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Medtronic_Resolute%20Integrity%20stent.jpg?itok=7eGGO3T8)
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago ...
![The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Cook_Zilver%20PTX_StentAnatomy.jpg?itok=daBIOmqT)
The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since 2003 ...
The rise cardiovascular disease has been instrumental in fueling the coronary stent market share in the past few years ...
January 17, 2019 — The U.S. Food and Drug Administration (FDA) issued a letter Jan. 17, 2019, to healthcare providers ...